Concepedia

Publication | Closed Access

Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer

172

Citations

26

References

2006

Year

Abstract

Docetaxel/S-1 combination is highly active and well tolerated in advanced or recurrent gastric cancer. Further investigation in randomized studies is warranted.

References

YearCitations

Page 1